Swissmedic
SAFETY ALERT
Reassessment of the safety of blood transfusions with regard to vCJD
Published: 1/13/2026Detected: 3/26/2026
Summary preview
Reassesses the risk of transmissible spongiform encephalopathy (vCJD) associated with blood transfusions and supports updating risk-management expectations for donor screening, processing, and safety controls.
Get the full analysis, free
Create a free account to see the complete summary, key takeaways, and why this matters for your products, and to get alerts like this by email.
Create free accountOfficial Source Document Source Verified
Access the original document directly from SWISSMEDIC.
More from Swissmedic
- Extended deadline for publishing officially mandated information materials on the electronic publication platform11/12/2026
- Designer drugs: FDHA brings further psychoactive substances under control11/10/2026
- NAD+ supplements: When lifestyle products have criminal consequences11/9/2026
- Publication eCTD v4.0 Implementation Guide Package v2.011/9/2026
- Save the Date: Clinical Trials Symposium 202711/4/2026